These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33109625)

  • 1. Association Between IL-5 Levels and the Clinicopathologic Features of Eosinophilic Granulomatosis With Polyangiitis.
    Nishi R; Koike H; Ohyama K; Fukami Y; Iijima M; Sobue G; Katsuno M
    Neurology; 2021 Feb; 96(5):226-229. PubMed ID: 33109625
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA.
    Nishi R; Koike H; Ohyama K; Fukami Y; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    Neurology; 2020 Apr; 94(16):e1726-e1737. PubMed ID: 32217776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyangiitis overlap syndrome: a novel presentation of microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Rasheed N; Ahuja R; Borneo H
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33526532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic granulomatosis with polyangiitis presenting with myositis: case based review.
    Koppikar S; Al-Dabie G; Jerome D; Vinik O
    Rheumatol Int; 2020 Jul; 40(7):1163-1170. PubMed ID: 32270295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyneuropathy with demyelinating changes in Churg-Strauss syndrome: an unusual association.
    Pati AR; Capecchi PL; Malandrini A; Federico A; Mignarri A
    Neurol Sci; 2017 Apr; 38(4):695-697. PubMed ID: 28025723
    [No Abstract]   [Full Text] [Related]  

  • 6. The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.
    Corral-Gudino L; González-Vázquez E; Calero-Paniagua I; Pérez-Garrido L; Cusacovich I; Rivas-Lamazares A; Quesada-Moreno A; González-Fernández A; Mora-Peña D; Lerma-Márquez JL; Del-Pino-Montes J
    Rheumatol Int; 2020 Feb; 40(2):303-311. PubMed ID: 31385079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L27. Antibodies versus phenotypes: a clinician's view.
    Jayne D
    Presse Med; 2013 Apr; 42(4 Pt 2):579-82. PubMed ID: 23490640
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotinylation of ANCA target antigen improves assay performance for PR3-ELISA but not MPO-ELISA.
    Hayman MW; Slade CA; Spellerberg MB; O'Donnell JL
    Pathology; 2013 Aug; 45(5):525-7. PubMed ID: 23842044
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-neutrophil cytoplasmic antibody(ANCA), MPO-ANCA, PR3-ANCA].
    Takizawa H
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():694-6. PubMed ID: 20942166
    [No Abstract]   [Full Text] [Related]  

  • 10. Uncommon pathological findings in sural nerve biopsy from a patient with Churg-Strauss related multiple mononeuropathy.
    Luigetti M; Del Grande A; Romano A; Sabatelli M
    Acta Reumatol Port; 2013; 38(4):286-9. PubMed ID: 24435033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute fulminant neuropathy in a patient with Churg-Strauss syndrome.
    Ng KK; Yeung HM; Loo KT; Chan HM; Wong CK; Li PC
    Postgrad Med J; 1997 Apr; 73(858):236-8. PubMed ID: 9156128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two subtypes of Churg-Strauss syndrome with neuropathy: the roles of eosinophils and ANCA.
    Oka N; Kawasaki T; Matsui M; Shigematsu K; Unuma T; Sugiyama H
    Mod Rheumatol; 2011 Jun; 21(3):290-5. PubMed ID: 21188447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis.
    Kim DS; Song JJ; Park YB; Lee SW
    Int J Rheum Dis; 2017 Sep; 20(9):1261-1268. PubMed ID: 28261989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
    Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L29. Relevance of anti-LAMP-2 in vasculitis: why the controversy.
    Kain R
    Presse Med; 2013 Apr; 42(4 Pt 2):584-8. PubMed ID: 23453500
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe polyneuropathy in a patient with Churg-Strauss syndrome.
    Bazzi P; Tancredi L; Scarpini E; Messina S; Sciacco M; Livraghi S; Vanoli M; Prelle A; Scarlato G; Moggio M
    J Peripher Nerv Syst; 2000 Jun; 5(2):106-10. PubMed ID: 10905470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
    Holle JU
    Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.